Moderator of 1 Session
Session Type
Industry-Sponsored Symposium
Date
Wed, 22.06.2022
Session Time
07:30 - 08:30
Room
Grand Ballroom Centre
Session Description
Product and Clinical development of a 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL®) - Supported by Serum Institute of India
A new Polysaccharide Conjugate Vaccine, PNEUMOSIL® has been licensed by Government of India and prequalified by WHO. This session covers the CMC and Clinical development of this vaccine which is likely to make a very positive public health impact in MICs and LMICs.
A new Polysaccharide Conjugate Vaccine, PNEUMOSIL® has been licensed by Government of India and prequalified by WHO. This session covers the CMC and Clinical development of this vaccine which is likely to make a very positive public health impact in MICs and LMICs.